Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. (Q36495076)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. |
scientific article |
Statements
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials (English)
Lalitha K Shankar
John M Hoffman
Steve Bacharach
Michael M Graham
Joel Karp
Adriaan A Lammertsma
Steven Larson
David A Mankoff
Barry A Siegel
Annick Van den Abbeele
Daniel Sullivan
National Cancer Institute